Back
XBiotech 10K Form
Buy
54
XBIT
XBiotech
Last Price:
7.05
Seasonality Move:
20.73%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-09 | 10Q | XBIT/XBiotech Quarterly |
| 2023-08-11 | 10Q | XBIT/XBiotech Quarterly |
| 2023-05-10 | 10Q | XBIT/XBiotech Quarterly |
| 2022-11-09 | 10Q | XBIT/XBiotech Quarterly |
| 2022-08-10 | 10Q | XBIT/XBiotech Quarterly |
| 2022-05-10 | 10Q | XBIT/XBiotech Quarterly |
Receive XBIT News And Ratings
See the #1 stock for the next 7 days that we like better than XBIT
XBIT Financial Statistics
Sales & Book Value
| Annual Sales: | $4.01M |
|---|---|
| Cash Flow: | $-6.18M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.30 |
| Price / Book: | 1.05 |
Profitability
| EPS (TTM): | -1.08000 |
|---|---|
| Net Income (TTM): | $-32.66M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
XBiotech Earnings Forecast
Key XBiotech Financial Ratios
- The Selling, General & Administrative Expenses for XBIT have been equal to 157.23% of Gross Profit Margin.
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 12 years have been positive in 5 years.
XBiotech Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | XBIT |
| CUSIP: | 98400H |
| Website: | xbiotech.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |